Trial Profile
Clofarabine, Idarubicin, and Cytarabine Combination as Induction Therapy for Younger Patients With Acute Myeloid Leukemia (AML).
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 11 Oct 2018
Price :
$35
*
At a glance
- Drugs Clofarabine (Primary) ; Cytarabine (Primary) ; Idarubicin (Primary)
- Indications Acute myeloid leukaemia
- Focus Therapeutic Use
- 01 Feb 2013 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 01 Sep 2011 Status changed from recruiting to active, no longer recruiting as reported by M.D. Anderson Cancer Center.
- 09 Mar 2011 New source identified and integrated (M.D. Anderson Cancer Center).